Safety Data on the Novel Pancreatic Cancer Drug Available by Early Access

MedPage Today·May 6

This story is reported by MedPage Today. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Activity Observed with Novel KRAS Inhibitor in Pancreatic Cancer

The ASCO Post·Mar 25

2

Zoldonrasib combinations show encouraging response rates in KRAS G12D-mutant pancreatic cancer

ESMO Daily Reporter·Jul 3

3

Novel ADC Combo Shows Efficacy in Phase 2 Bladder Cancer Data

Oncology News Central·May 31

4

Encouraging Survival, Safety Data for Atebimetinib Combo in Pancreatic Cancer

Targeted Oncology·Oct 7

5

SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trial

Nature·Mar 19

6

NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer

OncLive·Jan 27

7

Zymeworks to Present Clinical and Preclinical Data on ADC

GlobeNewswire·Mar 17

8

Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026

Business Wire·Apr 20